Drugs / HTS-519 Insert
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02798380 | Jul 2016 → Oct 2018 | tinea unguium | Hallux, Inc. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HTS-519 Insert | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02798380 ↗ |